JW Pharmaceutical Corporation

₩22,600As of Sun 8 Nov 2026, 12:00 UTC
KRX:001060Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (4.47%)
Div yield 2.88%
ROE 27.63%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.03
PE TTM 5.484
TSR TTM (1.78%)
Mkt cap ₩516.1B
ROIC 25.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩27,190
20.31%
(13.36%)
Hold 8|9|11|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
441.25
468.09
454.39
477.63
13.27%
8.22%
3.86%
10.59%
Revenue₩B
34.88
34.66
34.74
36.48
4.44%
5.65%
5.23%
6.63%
Peers (US$380.5M)
Cap (US$)
PE
499.0M
3.720x
Capital
TTM
5Y
10Y
Leveragex
6.635
(0.587)
(0.546)
EBIT/Intx
0.442
0.073
0.084
Own earn%
(65.17)
198.86
181.87
Sh yield%
52.72
37.66
38.13
Owners
Insiders/Inst%
1.26
73.21
Short interest%
5.83
SBC / revenue%
5.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
1